Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
about
Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.The cannabis withdrawal syndrome: current insightsDelirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic Cannabinoid WithdrawalIn vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).Psychostimulant Effect of the Synthetic Cannabinoid JWH-018 and AKB48: Behavioral, Neurochemical, and Dopamine Transporter Scan Imaging Studies in Mice.Synthetic Pot: Not Your Grandfather's Marijuana.Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.Role of cannabis in cardiovascular disorders.Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073.Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.Electrocardiographic alterations in patients consuming synthetic cannabinoids.Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ-THCEpigenetic Effects of Drugs of AbuseThe Chameleon-Like Properties of Psychoactive Drugs: Examinations with HR LC-MS/MS Technology of Patients Presenting at the Emergency Department Following the Use of Synthetic Cannabinoids: A Case Series and Literature Review
P2860
Q30244676-D59C8D06-B0CC-4A0F-946C-F5E4575A3E51Q30313180-46F513D0-C940-4DF7-B645-071ABE4BCDFCQ33594167-B7666CDA-2F4D-4486-826D-9339B3588E32Q34553148-F6A712B9-0EA7-48A6-A68D-44029318FC6BQ38616780-D77C03C5-95D3-45F6-BE30-623FF21C6C6FQ39120303-A9D5381B-4F0C-4F2D-8B9E-DA5CF94B2E31Q40635860-0A1A26DD-C3E7-4C52-8829-35ED36B1A8A1Q41242026-2C019BBC-C2C9-4494-A262-E51149E3CA6DQ45073154-8D4A5871-5120-4B6A-84F9-11C7B2ED1E30Q46507836-83D98975-C847-43C3-99B2-6172723C246EQ47579706-CCC171B5-95AC-4707-9DF1-0FEAC16D351FQ53094148-36CF03B4-FF6B-4675-8097-0C8626E31A18Q57491573-4D893539-14C7-4E21-BBAC-4B3CBA434009Q58696937-9B527C74-4D10-4301-AC05-CBD1A56C0A34Q58702071-F198E535-B944-44B8-93C7-FB37321C2040
P2860
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@ast
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@en
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@nl
type
label
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@ast
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@en
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@nl
prefLabel
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@ast
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@en
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@nl
P2860
P1476
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
@en
P2860
P2888
P356
10.1007/S11920-016-0694-1
P407
P50
P577
2016-05-01T00:00:00Z
P6179
1004711699